Reproductive Medicine Center, The First Affiliated Hospital of Sun Yat-sen University, Zhoushan 2 Road, Guangzhou, Guangdong, People's Republic of China.
Guangdong Provincial Key Laboratory of Reproductive Medicine, The First Affiliated Hospital of Sun Yat-sen University, Zhoushan 2 Road, Guangzhou, Guangdong, People's Republic of China.
Reprod Biol Endocrinol. 2022 Mar 25;20(1):57. doi: 10.1186/s12958-022-00922-5.
To evaluate whether the incidence of hypertensive disorders of pregnancy (HDP) in pregnant women was related to endometriosis (EM), ovulation and embryo vitrification technology.
A retrospective cohort study was conducted on the clinical data of 3674 women who were treated with IVF / ICSI in the Reproductive Medicine Center of the First Affiliated Hospital of Sun Yat-sen University and maintained clinical pregnancy for more than 20 weeks. All pregnancies were followed up until the end of pregnancy. The follow-up consisted of recording the course of pregnancy, pregnancy complications, and basic situation of newborns.
Compared with NC-FET without EM, HRT-FET without EM was found to have a higher incidence of HDP during pregnancy (2.7% V.S. 6.1%, P<0.001); however, no significant difference was found in the incidence of HDP between NC-FET and HRT-FET combined with EM (4.0% V.S. 5.7%, P>0.05). In total frozen-thawed embryo transfer (total-FET), the incidence of HDP in the HRT cycle without ovulation (HRT-FET) was observed to be higher than that in the NC cycle with ovulation (NC-FET) (2.8% V.S. 6.1%, P<0.001). In patients with EM, no significant difference was found in the incidence of HDP between fresh ET and NC-FET (1.2% V.S. 4.0%, P>0.05).
EM does not seem to have an effect on the occurrence of HDP in assisted reproductive technology. During the FET cycle, the formation of the corpus luteum may play a protective role in the occurrence and development of HDP. Potential damage to the embryo caused by cryopreservation seems to have no effect on the occurrence of HDP.
评估子宫内膜异位症(EM)、排卵和胚胎玻璃化技术是否与妊娠高血压疾病(HDP)的发生有关。
对中山大学附属第一医院生殖医学中心接受体外受精/卵胞浆内单精子注射(IVF/ICSI)治疗并维持临床妊娠 20 周以上的 3674 名妇女的临床资料进行回顾性队列研究。所有妊娠均随访至妊娠结束。随访包括记录妊娠过程、妊娠并发症和新生儿基本情况。
与无 EM 的 NC-FET 相比,无 EM 的 HRT-FET 妊娠期间 HDP 的发生率更高(2.7%比 6.1%,P<0.001);然而,EM 联合 NC-FET 和 HRT-FET 之间 HDP 的发生率无显著差异(4.0%比 5.7%,P>0.05)。在总冻融胚胎移植(total-FET)中,无排卵的 HRT 周期(HRT-FET)中 HDP 的发生率高于有排卵的 NC 周期(NC-FET)(2.8%比 6.1%,P<0.001)。在 EM 患者中,新鲜胚胎移植和 NC-FET 之间 HDP 的发生率无显著差异(1.2%比 4.0%,P>0.05)。
EM 似乎不会影响辅助生殖技术中 HDP 的发生。在 FET 周期中,黄体的形成可能对 HDP 的发生和发展起到保护作用。胚胎冷冻保存对 HDP 的发生似乎没有影响。